• Biohaven Pharmaceuticals

Migraines Take a Toll

Migraine can take its toll on all aspects of someone's life. Learn more about how it has impacted 17-year old Katharyn and her mom, Lori, who also suffers, and what they are doing to help others learn about the disorder:

Biohaven Pharmaceuticals is studying an investigational drug, to potentially treat migraines in the pediatric population. If you or your child, between 12 and 18 years of age, suffer from migraine for at least 6 months you may qualify. Learn more about our pediatric migraine study.

19 views0 comments